Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TruTrace Technologies is a Canadian software company that developed blockchain-enabled SaaS products for product verification, traceability, and quality assurance. Its core offerings include StrainSecure for cannabis supply-chain traceability and TruTrace Enterprise for product lab testing, certificate-of-analysis management, and anti-counterfeit verification across industries including cannabis, food, cosmetics, nutraceuticals, and pharmaceuticals. In healthcare-related markets, the company has focused on medical cannabis data integrity, validated product information, and supply-chain transparency rather than drug discovery or therapeutic development. TruTrace has worked with partners such as Shoppers Drug Mart, Applied DNA Sciences, PharmaCentra, and Avicanna on verification, clinical-trial-support, and product-authentication initiatives. Although the company historically operated as a public issuer, its common shares were suspended in 2023 and delisted from the Canadian Securities Exchange in July 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TruTrace Technologies.